Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 04, 2025	Mar. 29, 2024
Cash flows from operating activities:
Net income	$ 26,650	$ 30,142
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization of property, equipment and leasehold improvements	2,492	2,324
Provision for contract losses and doubtful accounts	256	1,279
Stock-based compensation	8,179	7,340
Deferred income tax provision	(3,226)	1,600
Changes in operating assets and liabilities:
Accounts receivable	(5,637)	3,196
Prepaid expenses and other current assets	(3,331)	(2,193)
Change in operating leases	454	(614)
Accounts payable and accrued liabilities	11,595	2,577
Accrued payroll and employee benefits	(27,571)	(29,616)
Deferred revenues	(2,587)	(5,603)
Net cash provided by operating activities	7,274	10,432
Cash flows from investing activities:
Capital expenditures	(1,754)	(1,482)
Net cash used in investing activities	(1,754)	(1,482)
Cash flows from financing activities:
Payroll taxes for restricted stock units	(4,166)	(6,796)
Repurchase of common stock		(5,466)
Exercise of stock-based payment awards	484	618
Dividends and dividend equivalents rights	(16,367)	(15,583)
Net cash used in financing activities	(20,049)	(27,227)
Effect of foreign currency exchange rates on cash and cash equivalents	741	(208)
Net decrease in cash and cash equivalents	(13,788)	(18,485)
Cash and cash equivalents at beginning of period	258,901	187,150
Cash and cash equivalents at end of period	$ 245,113	$ 168,665